India confirms that it will export the antimalarial drug
hydroxychloroquine recommended by the President of the United States, Donald
Trump, as a treatment against Covid-19, whose pandemic has caused more
infections in the United States than in any other country in the world; more
than 330,000 cases and nearly 10,000 deaths. Thus, the Government of India
responds to the request of the US president, who dispatched this weekend with
Prime Minister Narendra Modi to request the lifting of the veto on the export
of the product imposed by the eastern country in March and insisted on Monday
in possible “retaliation” if you refuse to accept your request.
"India will license the sale of paracetamol and
hydroxychloroquine (HCQ) in adequate quantities for neighboring countries that
depend on our benefits," Foreign spokesman Anurag Srivastava said on
Tuesday about the drugs that the country, the largest producer of world
generics, banned their export on March 25. The end of the veto concerns 24
pharmaceutical ingredients with which antibiotics such as tinidazole,
erythromycin or vitamin B12 are composed. "We will supply these basic
drugs, in particular, to nations that have been hit hard by the pandemic,"
he added.
Contradicting his team of experts, notably Anthony Fauci,
director of the National Institute of Infectious Diseases, Trump again this
weekend insisted on the use of hydroxychloroquine, used against malaria, to
treat Covid-19, as already did last month. Then, the recommendation of this
drug - promising but not yet approved by science - caused its stocks in Nigeria
to run out, as well as a sudden stockpile in India, two days before the complete
closure of the Asian country, two weeks ago.
Post a Comment
We want to know your comments and concerns. Remember: Respect distinguishes us, education makes us different...